Discover Our Truly Integrated Clinical and Bioanalytical Solution


The True Meaning of Moving in Unison

Join our VP of Global Clinical Operations, Ingrid Holmes, and our VP of Laboratory Sciences, Lynne Le Sauteur, as they share the secrets to the success of our integrated clinical and bioanalytical solution. You won't want to miss this!

Watch the full interview or keep scrolling to jump to a specific section.

Dr Lynne Le Sauteur and Ingrid Holmes

  1. Proprietary Scheduling System:
    In this video, discover our game-changing, proprietary scheduling system, which is essential for hitting key client deliverables and managing internal milestones across departments and services with precision.

    Explore more about our innovative scheduling system here.

  2. Advantages of Being a Mid-Sized CRO:
    Flexibility and customized service are at the core of our operations. Our mid-sized stature allows for seamless communication between departments while offering comprehensive services.

    Discover the benefits of partnering with a flexible, mid-sized CRO here.

  3. Successful Project Case Study:
    In this interview, we highlight a real-world example of a challenging project where seamless communication and coordination, and the proximity of our lab and clinic were pivotal to exceeding client expectations and delivering outstanding results.

    See how we tackle complex projects successfully here.
  4. You may also be interested in the following webpages:


The Sinclair Nanopigᵀᴹ—The Other Non-rodent

Antisense oligonucleotides—or ASOs—are short, synthetic, single-stranded oligonucleotides  extensively used for altering RNA expression to reduce, restore, or modify protein expression via several distinct mechanisms. With possible applications extending to both neurological and non-neurological conditions, there is great potential for valuable new therapeutics.

Selecting the Ideal Dosage Form for Your Drug Development Program


Choose Wisely.

With decades of experience developing and manufacturing almost every dosage form on the market, our experts can guide you in selecting the optimal one for your drug development program.

Read the infographic to discover the pros and cons of the two most popular solid oral dosage forms to determine which is best for your molecule.

Ready to discuss your drug development and manufacturing needs? Send us a message.

Related resources that may interest you:


Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides

Medhealth Outlook Top 10 CRO Solution Providers—Altasciences: A Holistic Approach to Early-Phase Drug Development

Subscribe to